Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Satoshi Tateshima

Vascular & Interventional Radiology Los Angeles, CA Medical Doctor

NPI 1922042068 CMS profile 360233

100 Ucla Medical Plz Ste 100, Los Angeles, CA 90024

Open in the dashboard

General payments

$764,160

284 records reported · program years 2019–2025

Research payments

$4,675

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$1,050,363

5 holdings reported · through program year 2025

Research they led as principal investigator

$136,857 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Satoshi Tateshima of Los Angeles, CA is reported in the CMS Open Payments database as having received $764,160 across 284 general payments and $4,675 in research payments paid to them. Separately, studies naming them as principal investigator received $136,857 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $1,050,363 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $63,483 37
2024 General $38,411 40
2023 General $51,251 49
2022 General $56,863 40
2021 General $33,127 52
2021 Research $1,063 2
2020 General $13,739 28
2020 Research $3,613 4
2019 General $507,287 38
2025 Ownership $20,403 1
2024 Ownership $123,828 1
2023 Ownership $123,828 1
2022 Ownership $12,304 1
2019 Ownership $770,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Satoshi Tateshima
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Satoshi Tateshima were reported at $63,483. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Satoshi Tateshima Vascular & Interventional Radiology median Middle half National median
2019 $507,287 $422 $125–$1,555 $163
2020 $13,739 $200 $68–$652 $114
2021 $33,127 $280 $99–$866 $132
2022 $56,863 $433 $137–$1,497 $149
2023 $51,251 $506 $152–$2,019 $160
2024 $38,411 $556 $175–$1,930 $164
2025 $63,483 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corindus Inc. $485,406 4 payments
  2. Stryker Corporation $125,701 117 payments
  3. Medical Device Business Services, Inc. $95,911 57 payments
  4. Rapid Medical LTD $32,798 22 payments
  5. Medtronic USA, Inc. $12,184 26 payments
  6. Medtronic, Inc. $2,498 9 payments
  7. Penumbra, Inc. $2,052 3 payments
  8. Nippon Boehringer Ingelheim Co., Ltd. $1,500 1 payment
  9. Balt USA, LLC $1,028 9 payments
  10. Canon Medical Systems USA, Inc. $1,000 1 payment
  11. Other $4,083 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Current or prospective ownership or investment interest $484,500 1 payment
  2. Consulting Fee $187,782 76 payments
  3. Travel and Lodging $76,307 81 payments
  4. Food and Beverage $9,596 118 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,975 7 payments
  6. Honoraria $1,000 1 payment
Products named General payments · program years 2019–2025
  1. EMBOGUARD $61,051 30 payments
  2. SURPASS EVOLVE $33,635 26 payments
  3. COMANECI 17 $32,798 22 payments
  4. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $30,115 20 payments
  5. TGS $19,587 6 payments
  6. TARGET $19,072 17 payments
  7. TREVO $11,705 12 payments
  8. PULSERIDER $10,603 4 payments
  9. EMBOTRAP II Revascularization Device $9,808 11 payments
  10. SYNCHRO SELECT $8,923 12 payments
  11. Other $50,178 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $3,613 4 payments
  2. Medtronic, Inc. $1,063 2 payments

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$44,914

Medicare's payments for the services billed

Medicare patients

73

Average age 72

Services billed

251

38 women, 35 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 63%
Arthritis 47%
Diabetes 33%
Ischemic heart disease 30%
Chronic kidney disease 29%
Osteoporosis 27%
Atrial fibrillation 25%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

290 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record